Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2

On Feb. 12, CBL announced that its Board of Directors declared a regular cash dividend of $0.40 per common share for the quarter ending March 31. The dividend, which equates to an annual dividend payment of $1.60 per common share, is payable on March 31, to shareholders of record as of March 13.

Conference Call to Discuss Results Scheduled for 10:00 a.m. ET Today . NEW YORK, Feb. 14, 2025 /PRNewswire/ -- Newmark Group, Inc. (Nasdaq: NMRK) ("Newma

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease.